Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia

NCT01597440 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped insufficient enrollment

Conditions

Propionic Acidemia
Methylmalonic Acidemia

Interventions

DRUG: N-carbamylglutamate
OTHER: Standard of Care

Sponsor

Mendel Tuchman

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]